Physician
Pueblo Family Physicians LTD
Pueblo Family Physicians LTD was paid $9.43M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.
33Billing provider infoPUEBLO FAMILY PHYSICIANS LTD
PHOENIX, AZ 85015
PHOENIX, AZ 85015
33aNPI1790798072assigned 08/15/2006
33bProvider typeFamily Medicine Physician
28Total paid$9.43M
24GClaims472,982
24DCodes billed170
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Arizona
Rank by total paid#11 of 442
Median peer was paid$77K
This provider vs. median122×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,673 | $1.49M | |
| 2019 | 107,639 | $1.42M | |
| 2020 | 96,904 | $1.47M | |
| 2021 | 59,066 | $1.63M | |
| 2022 | 55,225 | $1.40M | |
| 2023 | 45,832 | $1.18M | |
| 2024incomplete | 27,643 | $845K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 53% | 83,779 | 66,096 | $5.02M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 29,091 | 25,421 | $1.34M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.3% | 3,862 | 3,640 | $312K |
| 95912 | 3.3% | 1,563 | 1,535 | $310K | |
| 95913 | 3.2% | 1,334 | 1,320 | $305K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 20,521 | 16,443 | $247K |
| 93922 | 2.5% | 4,167 | 3,897 | $232K | |
| 94060 | 1.9% | 4,973 | 4,598 | $182K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.8% | 2,056 | 1,927 | $166K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 1,995 | 1,916 | $130K |
| 93000 | 1.3% | 11,006 | 10,420 | $123K | |
| 99385 | 1.3% | 1,292 | 1,246 | $122K |
158 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 5,243 | $104K |
| 99401 | 1.1% | 3,698 | $100K | |
| 99386 | <1% | 758 | $81K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,057 | $81K |
| 90756 | <1% | 3,375 | $61K | |
| 90746 | <1% | 837 | $42K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 160 | $37K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 468 | $35K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,621 | $33K |
| 81002 | <1% | 14,163 | $32K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 540 | $27K |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 5,753 | $20K |
| 90732 | <1% | 336 | $19K | |
| 99000 | <1% | 8,979 | $17K | |
| 0013A | <1% | 242 | $15K | |
| 82947 | <1% | 7,754 | $15K | |
| 0011A | <1% | 393 | $15K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 10,594 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 518 | $14K |
| 0012A | <1% | 314 | $13K | |
| 99497 | <1% | 1,004 | $13K | |
| 0124A | <1% | 227 | $12K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 909 | $11K |
| 90739 | <1% | 117 | $11K | |
| 90682 | <1% | 452 | $9K | |
| 99397 | <1% | 314 | $9K | |
| G0008 | Administration of influenza virus vaccine | <1% | 2,986 | $8K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 82 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 271 | $7K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 1,340 | $6K |
| J3490 | Unclassified drugs | <1% | 3,321 | $6K |
| 81025 | <1% | 897 | $6K | |
| 90674 | <1% | 305 | $5K | |
| 0064A | <1% | 85 | $4K | |
| 90686 | <1% | 333 | $4K | |
| 99402 | <1% | 119 | $4K | |
| 90715 | <1% | 205 | $4K | |
| 96127 | <1% | 715 | $3K | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 1,755 | $2K |
| 99441 | <1% | 61 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,834 | $2K |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 1,710 | $2K |
| 90694 | <1% | 351 | $2K | |
| 90714 | <1% | 155 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,932 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 18 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 360 | $2K |
| 90688 | <1% | 143 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,200 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,157 | $2K |
| 90661 | <1% | 80 | $2K | |
| 90653 | <1% | 265 | $2K | |
| 0134A | <1% | 27 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 15 | $1K |
| 90632 | <1% | 26 | $1K | |
| 90480 | <1% | 46 | $880.00 | |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 160 | $828.82 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 112 | $792.34 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 53 | $691.76 |
| 97803 | <1% | 283 | $589.00 | |
| 99490 | Ccm add 20min | <1% | 187 | $491.60 |
| 86703 | <1% | 38 | $452.14 | |
| 69210 | <1% | 14 | $385.68 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 3,717 | $358.99 |
| 90662 | <1% | 119 | $326.99 | |
| 82272 | <1% | 230 | $319.45 | |
| 97802 | <1% | 99 | $175.00 | |
| 86580 | <1% | 26 | $156.69 | |
| 80305 | <1% | 21 | $87.20 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 74 | $65.49 |
| 69209 | <1% | 12 | $58.36 | |
| 82270 | <1% | 12 | $42.20 | |
| 99406 | <1% | 94 | $26.78 | |
| 1159F | <1% | 35,324 | $25.88 | |
| 1160F | <1% | 35,282 | $25.86 | |
| 96146 | <1% | 80 | $22.72 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 16 | $21.83 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 272 | $6.64 |
| G0009 | Administration of pneumococcal vaccine | <1% | 14 | $6.32 |
| 2010F | <1% | 6,343 | $5.85 | |
| 3074F | <1% | 18,753 | $3.75 | |
| 3079F | <1% | 10,547 | $3.59 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 8,053 | $1.90 |
| 3008F | <1% | 4,279 | $1.88 | |
| 3078F | <1% | 16,017 | $1.87 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 6,865 | $1.66 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 6,589 | $1.54 |
| 4013F | <1% | 4,432 | $1.45 | |
| 3044F | <1% | 2,482 | $1.25 | |
| 4293F | <1% | 1,171 | $1.08 | |
| 3075F | <1% | 5,771 | $0.96 | |
| 3048F | <1% | 708 | $0.96 | |
| 3500F | <1% | 805 | $0.76 | |
| 4270F | <1% | 796 | $0.76 | |
| 0575F | <1% | 805 | $0.75 | |
| 4010F | <1% | 664 | $0.70 | |
| 3512F | <1% | 586 | $0.69 | |
| 3502F | <1% | 693 | $0.66 | |
| 3077F | <1% | 3,614 | $0.62 | |
| 1125F | <1% | 2,879 | $0.57 | |
| 3011F | <1% | 734 | $0.52 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | <1% | 1,785 | $0.49 |
| 3028F | <1% | 495 | $0.47 | |
| 3511F | <1% | 430 | $0.42 | |
| 3080F | <1% | 2,314 | $0.39 | |
| 1034F | <1% | 1,245 | $0.29 | |
| 91312 | <1% | 66 | $0.26 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | <1% | 611 | $0.25 |
| 0521F | <1% | 384 | $0.24 | |
| 91320 | <1% | 44 | $0.22 | |
| 4086F | <1% | 1,163 | $0.20 | |
| 3049F | <1% | 223 | $0.19 | |
| 3050F | <1% | 149 | $0.19 | |
| 1000F | <1% | 98 | $0.15 | |
| 3498F | <1% | 82 | $0.13 | |
| 3514F | <1% | 16 | $0.07 | |
| 3496F | <1% | 16 | $0.07 | |
| 3513F | <1% | 15 | $0.07 | |
| 4037F | <1% | 114 | $0.06 | |
| 4274F | <1% | 1,717 | $0.05 | |
| 2000F | <1% | 342 | $0.04 | |
| 1036F | <1% | 3,184 | $0.04 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 281 | $0.04 |
| 3016F | <1% | 14 | $0.04 | |
| 2001F | <1% | 704 | $0.03 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 610 | $0.03 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 178 | $0.03 |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 580 | $0.03 |
| 4210F | <1% | 41 | $0.02 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | <1% | 315 | $0.02 |
| G8482 | Influenza immunization administered or previously received | <1% | 986 | $0.02 |
| G9744 | Patient not eligible due to active diagnosis of hypertension | <1% | 232 | $0.02 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | <1% | 425 | $0.02 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 744 | $0.02 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 456 | $0.01 |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | <1% | 281 | $0.01 |
| 1123F | 0% | 92 | $0.00 | |
| 3037F | 0% | 259 | $0.00 | |
| 3061F | 0% | 27 | $0.00 | |
| 3017F | 0% | 85 | $0.00 | |
| 3330F | 0% | 17 | $0.00 | |
| 1101F | 0% | 458 | $0.00 | |
| 1170F | 0% | 4,604 | $0.00 | |
| G8952 | Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given | 0% | 184 | $0.00 |
| 1111F | 0% | 1,121 | $0.00 | |
| 3503F | 0% | 16 | $0.00 | |
| 1157F | 0% | 158 | $0.00 | |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 102 | $0.00 |
| 4011F | 0% | 73 | $0.00 | |
| 99091 | 0% | 187 | $0.00 | |
| 4040F | 0% | 277 | $0.00 | |
| 3046F | 0% | 32 | $0.00 | |
| 3045F | 0% | 204 | $0.00 | |
| 4004F | 0% | 268 | $0.00 | |
| 99499 | 0% | 40 | $0.00 | |
| 1158F | 0% | 322 | $0.00 | |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 20 | $0.00 |
| 3725F | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNS, RICK (PRACTICE ADMINISTRATOR)
Parent organizationPUEBLO FAMILY PHYSICIANS LTD